Compound Summary
Compound Information
Tiliroside
Compound Name: | Tiliroside |
Compound CID: | 5320686 |
Synonyms: | Tiliroside 20316-62-5 Tribuloside Trans-Tiliroside UNII-15M04TXR9M More... |
Iupac Name: | [(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate |
InChI: | InChI=1S/C30H26O13/c31-16-6-1-14(2-7-16)3-10-22(35)40-13-21-24(36)26(38)27(39)30(42-21)43-29-25(37)23-19(34)11-18(33)12-20(23)41-28(29)15-4-8-17(32)9-5-15/h1-12,21,24,26-27,30-34,36,38-39H,13H2/b10-3+/t21-,24-,26+,27-,30+/m1/s1 |
InChIKey: | DVGGLGXQSFURLP-VWMSDXGPSA-N |
Canonical Smiles: | C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)O)O)O)O |
Isomeric Smiles: | C1=CC(=CC=C1/C=C/C(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)O)O)O)O |
Molecular Weight: | 594.5 |
Molecular Formula: | C30H26O13 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Tiliroside
Molecular Weight: | 594.5 |
Molecular Formula: | C30H26O13 |
Hydrogen Bond Donor Count: | 7 |
Hydrogen Bond Acceptor Count: | 13 |
Rotatable Bond Count: | 8 |
Heavy Atom Count: | 43 |
Complexity: | 1040 |
Synonyms
Tiliroside
| Tiliroside | Tiliroside |
|---|---|
Tiliroside |
20316-62-5 |
Tribuloside |
Trans-Tiliroside |
UNII-15M04TXR9M |
15M04TXR9M |
CHEMBL266564 |
CHEBI:80944 |
(2R,3S,4S,5R,6S)-6-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yloxy-3,4,5-trihydroxyoxan-2-ylmethyl (E)-3-(4-hydroxyphenyl)prop-2-enoate |
2-Propenoic acid, 3-(4-hydroxyphenyl)-, 6-ester with 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
(2R,3S,4S,5R,6S)-6-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-3-yloxy-3,4,5-trihydroxy-tetrahydropyran-2-ylmethyl (E)-3-(4-hydroxyphenyl)prop-2-enoate |
22153-44-2 |
SCHEMBL23597 |
Tiliroside, analytical standard |
MEGxp0_000169 |
6-O-trans-p-Coumaroylastragalin |
Kaempferol-3-(p-coumaryl)glucoside |
HY-N2443 |
BDBM50241244 |
MFCD00017454 |
ZINC17654711 |
AKOS015896718 |
MCULE-6075035042 |
NCGC00163634-01 |
CS-0022668 |
W1685 |
kaempferol 3-O-(6"-O-p-coumaroyl)-glucoside |
Kaempferol-3-O-(6-p-coumaroyl)-glucoside |
C17140 |
316T625 |
A814433 |
Q-100248 |
Q23418844 |
kaempferol-3-beta-D-(6-O-trans-p-coumaroyl)glucopyranoside |
Kaempferol-3-O-(6-O-trans-p-coumaroyl)-.beta.-glucopyranoside |
kaempferol-3-O-beta-D-(6-(E)-p-coumaroyl)-glucopyranoside" |
kaempferol 3-O-(6 -O-E-p-coumaroyl)-beta-D-glucopyranoside |
(E)-((2R,3S,4S,5R,6S)-6-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-yl)methyl 3-(4-hydroxyphenyl)acrylate |
(E)-((2R,3S,4S,5R,6S)-6-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl 3-(4-hydroxyphenyl)acrylate |
4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-6-O-(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl-.beta.-D-glucopyranosyloxy- |
5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4E-1-benzopyran-3-yl 6-O-(2E)-3-(4-hydroxyphenyl)prop-2-enoyl-beta-D-glucopyranoside |
Experimental Data
Tiliroside
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drosophila melanogaster | 100 | umol/L | 26.7 | 30.9 | 13.8 | 51 | 54 | 0.06 | S | Oregon-R | 28887920 | Active | |
| Drosophila melanogaster | 200 | umol/L | 26.7 | 29.4 | 10.3 | 51 | 52 | 0.02 | NS | Oregon-R | 28887920 | Inactive |
Experimental Data Visualization
Tiliroside
Statistics Data
Tiliroside
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Drosophila melanogaster | 13.8 | 0.06 | 1 | 2 |
Statistics Data Visualization
Tiliroside
